NEWPORT BEACH, Calif., (September 19, 2023) — CureDuchenne, a leading nonprofit organization dedicated to advancing research and improving the lives of individuals affected by Duchenne muscular dystrophy, is proud to […]
Annual Event Features Dinner, Drinks, Raffles, Fall Fashion Show Preview and More to Raise Funds to Help Find a Cure for Duchenne Muscular Dystrophy AUSTIN, Texas (August 15, 2023) – CureDuchenne, […]
Event Has Raised More Than $5.3 Million to Find a Cure for Duchenne Muscular Dystrophy NEWPORT BEACH, Calif., (August 14, 2023) – CureDuchenne, a leading global nonprofit focused on finding […]
NEWPORT BEACH, Calif., (July 31, 2023) — The second annual Cali-RAD Fest (Reggae Against Duchenne) will return to The Beach House in Mission Beach on September 2, 2023, to benefit […]
NEW YORK, June 15, 2023 – CureDuchenne, Muscular Dystrophy Association (MDA), and Parent Project Muscular Dystrophy (PPMD), today announced a collaborative clinical trial grant to test repurposing of the FDA-approved […]
Tickets and Sponsorships Available in Support of Nonprofit Dedicated to Finding and Funding Cure for Duchenne Muscular Dystrophy Knoxville, TN. (June 5, 2023) – Knoxville Brewfest, the city’s most anticipated […]
“CureDuchenne is a leader in funding pioneering research aimed at advancing the best possible therapies for DMD patients, and we value their vote of confidence and financial support of our snRNA-mediated exon skipping platform,” said Jim Burns, Ph.D., Locanabio’s chief executive officer.
Newport Beach, Calif. (May 11, 2023) – CureDuchenne Ventures announced funding for MyoGene Bio, LLC, a biotech company developing a novel gene editing therapy for Duchenne muscular dystrophy (DMD). […]
CureDuchenne Ventures announces an investment in Insmed Inc. to support the development of INS1201, their next generation intracerebroventricular (ICV) delivered AAV to directly address limitations of current gene therapy approaches.
